These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32380355)

  • 21. Safety, Tolerability, and Pharmacokinetics of Tazarotene Clindamycin Cream: A Single-Dose, 3-Period Crossover Study.
    Li L; Zhang XF; Yang GP; Huang J; Yang XY; Ye L; Guo C; Yang S; Wang XM
    Clin Pharmacol Drug Dev; 2021 Jun; 10(6):598-606. PubMed ID: 33241616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous determination of indapamide, perindopril and perindoprilat in human plasma or whole blood by UPLC-MS/MS and its pharmacokinetic application.
    Tao Y; Wang S; Wang L; Song M; Hang T
    J Pharm Anal; 2018 Oct; 8(5):333-340. PubMed ID: 30345148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro compatibility of tazarotene with other topical treatments of psoriasis.
    Hecker D; Worsley J; Yueh G; Lebwohl M
    J Am Acad Dermatol; 2000 Jun; 42(6):1008-11. PubMed ID: 10827404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a Once-Daily Fixed Combination Halobetasol (0.01%) and Tazarotene (0.045%) Lotion in the Treatment of Localized Moderate-to-Severe Plaque Psoriasis.
    Blauvelt A; Green LJ; Lebwohl MG; Yamauchi PS; Lin T; Martin G; Pillai R
    J Drugs Dermatol; 2019 Mar; 18(3):297-299. PubMed ID: 30909352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous analysis of glucocorticosteroid fluticasone propionate and its metabolite fluticasone propionate 17β-carboxylic acid in human plasma by UPLC-MS/MS at sub pg/mL level.
    Nair SG; Patel DP; Sanyal M; Singhal P; Shrivastav PS
    J Pharm Biomed Anal; 2017 Feb; 135():1-7. PubMed ID: 27987390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into the degradation chemistry of tazarotene, a third generation acetylenic retinoid: LC-HRMS (Orbitrap), LC-MS
    Singh DK; Sahu A; Balhara A; Giri S; Singh S
    J Pharm Biomed Anal; 2020 Jul; 186():113316. PubMed ID: 32413825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous determination of lovastatin and its metabolite lovastatin acid in rat plasma using UPLC-MS/MS with positive/negative ion-switching electrospray ionization: Application to a pharmacokinetic study of lovastatin nanosuspension.
    Guo M; Zhao L; Li M; Fu Q; Pu X; Liu B; He Z; Yang L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1023-1024():55-61. PubMed ID: 27200472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy.
    J Drugs Dermatol; 2019 Aug; 18(8):815-820. PubMed ID: 31424713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials.
    Lebwohl MG; Sugarman JL; Stein Gold L; Lin T; Israel R
    J Drugs Dermatol; 2019 Oct; 18(10):1012-1018. PubMed ID: 31584780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of Clobetasol-17-Propionate in Psoriatic Lesional and Non-Lesional Skin Assessed by Dermal Open Flow Microperfusion with Time and Space Resolution.
    Bodenlenz M; Dragatin C; Liebenberger L; Tschapeller B; Boulgaropoulos B; Augustin T; Raml R; Gatschelhofer C; Wagner N; Benkali K; Rony F; Pieber T; Sinner F
    Pharm Res; 2016 Sep; 33(9):2229-38. PubMed ID: 27271272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Halobetasol and Tazarotene: Further Defining the Role of a Unique Fixed Combination Topical Lotion in Moderate-to-Severe Plaque Psoriasis.
    Stein Gold L; Bagel J; Lebwohl M; Lin T; Martin G; Pillai R
    J Drugs Dermatol; 2018 Dec; 17(12):1290-1296. PubMed ID: 30586261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid and sensitive UPLC-MS/MS method for determination of HZ08 in rat plasma and tissues: application to a pharmacokinetic study of liposome injections.
    Yan F; Sun M; Hang T; Sun J; Zhou X; Deng X; Ge L; Qian H; Ya D; Huang W
    J Pharm Biomed Anal; 2015 Jan; 102():246-52. PubMed ID: 25305722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid chromatography-tandem mass spectrometric assay for clobetasol propionate in human serum from patients with atopic dermatitis.
    Sparidans RW; van Velsen SG; de Roos MP; Schellens JH; Bruijnzeel-Koomen CA; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(23):2150-4. PubMed ID: 20605116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tazarotene--first of a new generation of receptor-selective retinoids.
    Chandraratna RA
    Br J Dermatol; 1996 Oct; 135 Suppl 49():18-25. PubMed ID: 9035701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model.
    Sun J; Dou W; Zhao Y; Hu J
    Immunopharmacol Immunotoxicol; 2014 Feb; 36(1):17-24. PubMed ID: 24286371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromatographic method for clobetasol propionate determination in hair follicles and in different skin layers.
    Ângelo T; Cunha-Filho MS; Gelfuso GM; Gratieri T
    Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27502902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and safety of tazarotene.
    Menter A
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S31-5. PubMed ID: 10898827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Efficacy of a Fixed Combination Halobetasol and Tazarotene Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Pooled Analysis of Two Phase 3 Studies.
    Sugarman JL; Weiss J; Tanghetti EA; Bagel J; Yamauchi PS; Stein Gold L; Lin T; Martin G; Pillai R; Israel R
    J Drugs Dermatol; 2018 Aug; 17(8):855-861. PubMed ID: 30124724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful Treatment of Lichen Amyloidosis Using a Fixed Combination of Halobetasol-Propionate and Tazarotene Lotion.
    Shoen E; Hou A; Zahn J; Friedman A
    J Drugs Dermatol; 2021 Mar; 20(3):336-337. PubMed ID: 33683084
    [No Abstract]   [Full Text] [Related]  

  • 40. Topical clobetasol propionate in the treatment of psoriasis: a review of newer formulations.
    Feldman SR; Yentzer BA
    Am J Clin Dermatol; 2009; 10(6):397-406. PubMed ID: 19824740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.